25021-174 : Daptomycin 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 25021-174
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Daptomycin
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA207104
Rev. Date: 


NDC Package Codes:

  • 25021-174-15: 1 VIAL IN 1 CARTON (25021‑174‑15) > 10 ML IN 1 VIAL
  • 25021-174-16: 10 VIAL IN 1 CARTON (25021‑174‑16) > 10 ML IN 1 VIAL

Active Ingredients:

  • Daptomycin

Dosage Strength:

  • 50 mg/mL

Pharmaceutical Classes:

  • Lipopeptide Antibacterial [EPC]
  • Lipopeptides [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 25021-179 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 0143-9378 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0409-0106 Daptomycin 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-0120 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-0122 Daptomycin 500 mg/10mg Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-2757 Daptomycin 500 mg/10ml Intravenous Injection, Powder, for Solution by Hospira Inc.
  • 0409-5933 Daptomycin 350 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Inc.
  • 0703-0125 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Teva Parenteral Medicines, Inc.
  • 0781-3295 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc.
  • 14335-120 Daptomycin 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Suspension by Hainan Poly Pharm., Co., Ltd.
  • 16714-892 Daptomycin 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16729-434 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare, Inc.
  • 16729-435 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 31722-102 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals Inc.
  • 31722-215 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
  • 31722-216 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
  • 43598-413 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr.reddy's Laboratories Inc.,
  • 43598-476 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 45932-0039 Daptomycin 350 mg/7ml Intravenous Injection, Powder, Lyophilized, for Solution by Xellia Pharmaceuticals USA, LLC
  • 55150-344 Daptomycin 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-174 QR Code

< Prev: 25021-173Next: 25021-175 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.